Burzynski Research Company Executives
| BZYR Stock | USD 0.03 0 8.33% |
Burzynski Research employs about 6 people. The company is managed by 6 executives with a total tenure of roughly 116 years, averaging almost 19.0 years of service per executive, having 1.0 employees per reported executive. Discussion of Burzynski Research's management performance can provide insight into the enterprise performance.
| Stanislaw Burzynski Chairman Chairman of the Board and Presidentident |
| Tomasz Janicki President Vice President - Clinical Trials |
Burzynski |
Burzynski Research Management Team Effectiveness
The company has return on total asset (ROA) of (127.6631) % which means that it has lost $127.6631 on every $100 spent on assets. This is way below average. Burzynski Research's management efficiency ratios could be used to measure how well Burzynski Research manages its routine affairs as well as how well it operates its assets and liabilities.Burzynski Research Workforce Comparison
Burzynski Research is rated below average in number of employees category among related companies. The total workforce of Health Care industry is currently estimated at about 3,313. Burzynski Research adds roughly 6.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Burzynski Research Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Burzynski Research Price Series Summation is a cross summation of Burzynski Research price series and its benchmark/peer.
Burzynski Research Notable Stakeholders
A Burzynski Research stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Burzynski Research often face trade-offs trying to please all of them. Burzynski Research's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Burzynski Research's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Stanislaw Burzynski | Chairman of the Board and Presidentident | Profile | |
| Tomasz Janicki | Vice President - Clinical Trials | Profile | |
| Barbara Burzynski | Director | Profile | |
| Carlton Hazlewood | Director | Profile | |
| Gregory Burzynski | Director | Profile | |
| Patryk Goscianski | Treasurer, Secretary | Profile |
About Burzynski Research Management Performance
The success or failure of an entity such as Burzynski Research often depends on how effective the management is. Burzynski Research management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Burzynski management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Burzynski management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs to treat cancer. Burzynski Research Institute, Inc. was founded in 1977 and is based in Houston, Texas. Burzynski Research is traded on OTC Exchange in the United States.
The data published in Burzynski Research's official financial statements usually reflect Burzynski Research's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Burzynski Research. For example, before you start analyzing numbers published by Burzynski accountants, it's critical to develop an understanding of what Burzynski Research's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Burzynski Research's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Burzynski Research's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Burzynski Research's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Burzynski Research. Please utilize our Beneish M Score to check the likelihood of Burzynski Research's management manipulating its earnings.
Burzynski Research Workforce Analysis
Traditionally, organizations such as Burzynski Research use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Burzynski Research within its industry.Burzynski Research Manpower Efficiency
Return on Burzynski Research Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 162.8K | |
| Net Loss Per Executive | 162.8K |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Burzynski Research. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Burzynski Pink Sheet analysis
When running Burzynski Research's price analysis, check to measure Burzynski Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Burzynski Research is operating at the current time. Most of Burzynski Research's value examination focuses on studying past and present price action to predict the probability of Burzynski Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Burzynski Research's price. Additionally, you may evaluate how the addition of Burzynski Research to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |